Executive Director Update – November 2026
A Season of Gratitude, Optimism, and Renewed Commitment to Vision Research
As we approach Thanksgiving and reflect on the past year, I want to express my gratitude to all our partners and stakeholders in the vision research and patient advocacy communities for your continued engagement, partnership, and commitment to advancing research that protects sight and improves lives.
The past year or two has brought significant challenges and uncertainty for our nation’s biomedical research enterprise. From threats to federal research funding and proposed changes to the structure and administration of the National Institutes of Health (NIH), to policies that could fundamentally alter how research is reviewed, funded, and conducted, our community has been called upon repeatedly to make its voice heard.
Through it all, our collective advocacy has made a difference.
The recent congressional elections provide reasons for cautious optimism as we look toward 2027. With new leadership in the House and Senate, changing committee assignments, and a substantial incoming class of lawmakers, there will be important opportunities to strengthen support for biomedical research and reaffirm the longstanding bipartisan commitment to scientific discovery.
Our priorities remain unchanged regardless of which party controls Congress, and NIH has always received bipartisan support. We will continue working with Republicans and Democrats alike to secure sustained funding increases for the National Eye Institute (NEI), preserve its independence within NIH, protect scientific merit and peer review, and ensure that federal research policies support rather than impede scientific progress.
We are particularly encouraged by indications that incoming congressional leaders have indicated their intent to prioritize renewed investment in NIH. At the same time, we recognize that election outcomes alone do not guarantee progress. Continued advocacy, constructive bipartisan engagement, and sustained attention to federal funding and research policies will be essential.
The coming year also represents an extraordinary opportunity to introduce newly elected members of Congress to the importance of vision research. With a large freshman class entering the House and Senate, we have an opportunity to build new relationships, educate policymakers about the burden of eye disease and vision loss, and demonstrate how federal investment in vision science improves health, supports innovation, and strengthens communities across the country.
Our work begins now as the current Congress wraps up, not when the new Congress convenes.
In the remaining weeks of 2026, we will continue advocating for strong FY2027 funding for NEI and NIH, renewed investment in the Department of Defense’s Vision Research Program, and protections against proposed changes to federal grants management that threaten the integrity and independence of scientific research.
We are also developing comments on NIH’s proposal to expand annual reporting requirements for animals used in research, with comments due December 21. We encourage researchers and institutions to review the proposal and provide feedback to help ensure that any new requirements are scientifically meaningful, appropriately designed, and do not impose unnecessary administrative burdens.
I encourage each of you to contact your members of Congress before the end of the year and again as the new Congress begins. Share your research, your experiences, and the ways vision science is making a difference for patients and families. Personal stories and direct engagement remain among our most effective advocacy tools.
As we prepare for the opportunities and challenges ahead, I am reminded of the strength of our partners and community. Our progress is possible because researchers, clinicians, patients, advocates, professional societies, industry, and organizations across the country are willing to work together in support of a common goal.
This Thanksgiving, I am especially thankful for your partnership and for the dedicated scientists and advocates whose work brings us closer to preventing vision loss, developing new treatments, and restoring sight.
On behalf of the Alliance for Vision Research, I wish you and your families a wonderful Thanksgiving filled with warmth, gratitude, and time with those who matter most.
Sincerely,
Dan Ignaszewski
Executive Director
Alliance for Vision Research